Aurora Spine Corporation
ASG.V
TSX
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | 4.77M | 4.08M | 4.01M | 4.04M | 3.95M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 4.77M | 4.08M | 4.01M | 4.04M | 3.95M |
| Cost of Revenue | 1.88M | 1.53M | 1.53M | 1.75M | 1.59M |
| Gross Profit | 2.88M | 2.55M | 2.48M | 2.30M | 2.36M |
| SG&A Expenses | 2.39M | 2.28M | 2.23M | 1.94M | 2.05M |
| Depreciation & Amortization | 237.30K | 210.60K | 298.70K | 291.30K | 293.30K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 4.65M | 4.19M | 4.24M | 4.28M | 4.15M |
| Operating Income | 114.50K | -111.60K | -222.30K | -238.10K | -199.70K |
| Income Before Tax | 71.10K | -154.10K | -266.90K | -285.60K | -249.60K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 71.10K | -154.10K | -266.90K | -285.60K | -249.60K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 71.10K | -154.10K | -266.90K | -285.60K | -249.60K |
| EBIT | 114.50K | -111.60K | -222.30K | -238.10K | -199.70K |
| EBITDA | 261.20K | 14.80K | -4.40K | -27.40K | 13.00K |
| EPS Basic | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Average Basic Shares Outstanding | 77.42M | 77.42M | 77.42M | 75.49M | 69.06M |
| Average Diluted Shares Outstanding | 77.42M | 77.42M | 77.42M | 75.49M | 69.06M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
